© Copyright 2025 American Medical Association. All rights reserved.
The CPT® Code 90625 refers to the cholera vaccine, which is a live vaccine specifically formulated for adult dosage and administered in a one-dose schedule for oral use. Vaccines, unlike immune globulins that offer short-term, passive immunity, provide active, long-term immunity. This is achieved by introducing altered versions of specific pathogens, such as viruses or bacteria, into the recipient's immune system. The immune system then responds by producing its own antibodies against these invaders, creating a memory that enables the body to respond more effectively upon future exposures to the same antigens. The cholera vaccine is designed to protect against cholera, an acute diarrheal disease caused by the bacterium Vibrio cholerae. While cholera is not commonly found in industrialized nations, it remains prevalent in regions such as sub-Saharan Africa and the Indian subcontinent. The disease can lead to severe dehydration, cramping, and shock, potentially resulting in death within hours if not treated promptly. It is important to note that this code specifically reports the vaccine product used, rather than any associated services or administration details.
© Copyright 2025 Coding Ahead. All rights reserved.
The cholera vaccine (CPT® Code 90625) is indicated for individuals who are at risk of exposure to cholera, particularly in areas where the disease is endemic. The following conditions and situations warrant the administration of this vaccine:
The administration of the cholera vaccine involves the following procedural steps:
Following the administration of the cholera vaccine, patients are advised to maintain hydration and monitor for any side effects, which may include mild gastrointestinal symptoms. It is important for patients to understand that while the vaccine provides protection against cholera, it does not guarantee complete immunity. Therefore, continued adherence to safe food and water practices is recommended, especially when traveling to areas where cholera is prevalent. Patients should also be informed about the signs and symptoms of cholera and advised to seek medical attention if they experience severe diarrhea or vomiting.
| Short Descr | CHOLERA VACCINE LIVE ORAL | Medium Descr | CHOLERA VACCINE ADULT 1 DOSE LIVE FOR ORAL USE | Long Descr | Cholera vaccine, live, adult dosage, 1 dose schedule, for oral use | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Non-Covered Service, not paid under OPPS | Type of Service (TOS) | 1 - Medical Care | Berenson-Eggers TOS (BETOS) | P6D - Minor procedures - other (non-Medicare fee schedule) | MUE | 1 |
| GY | Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2016-06-10 | Changed | FDA Approval |
| 2016-01-01 | Added | Added |
Get instant expert-level medical coding assistance.